# American Blood Bank Corp. – FDA Inspection, Sep 26, 2014

Source: https://www.keypedia.com/records/fda_inspections/american-blood-bank-corp/2a916c92-a28b-4cd2-b625-3d51a642a5dc
Source feed: FDA_Inspections

> FDA inspection 894213 of American Blood Bank Corp., September 26, 2014. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 606 and 610. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 894213
- Company Name: American Blood Bank Corp.
- Inspection Date: 2014-09-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1264839 - 2025-03-19
- FDA Inspection 1173726 - 2022-06-14
- [FDA Inspection 1098924 - 2019-08-07](https://www.keypedia.com/records/fda_inspections/american-blood-bank-corp/c86c9c2c-2762-4652-a4b5-411f23d4ec98)
- [FDA Inspection 980945 - 2016-05-19](https://www.keypedia.com/records/fda_inspections/american-blood-bank-corp/38fe29f6-ed9b-4cc9-b54c-8f0ce92f8805)
- FDA Inspection 799803 - 2012-09-19

Company: https://www.keypedia.com/companies/american-blood-bank-corp/71dd8d8c-0a55-4cf9-a5df-acdb245bf4e8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d